<DOC>
	<DOCNO>NCT01787305</DOCNO>
	<brief_summary>The purpose study explore certain commensal within gut microbiota ( collection microbes live inside gut ) correlate autoantibody autoimmune clot disorder call antiphospholipid syndrome . The study hypothesis particular commensal induce autoantibody ( immune molecule bind self structure ) thus correlate level immune cell antibodies self-reactive . Participants patient antiphospholipid syndrome individual test positive prior blood test anti-beta2-glycoprotein I antibodies test negative antiphospholipid antibody blood , clot event health problem put risk form blood clot .</brief_summary>
	<brief_title>Pilot Study Gut Commensals Antiphospholipid Syndrome</brief_title>
	<detailed_description>Antiphospholipid syndrome ( APS ) autoimmune disorder people risk form blood clot . Having positive antiphospholipid antibody ( aPL ) test mean person APS ; small number people develop APS . These antibody also occur otherwise healthy people . We believe certain bacteria gut may cause antibody produce . Current treatment APS target blood clot system goal prevent future blood clot . Many patient require therapy entire life . If persistent trigger find within gut microbiota , may help develop treatment . This study conduct two center , Yale University School Medicine New Haven , CT , The Hospital Special Surgery Manhattan , New York . We expect enroll total 40 subject study study site . Visits follow : Visit 1 : Initial screen visit : Review medical record questionnaire completion . Visit 2 ( one month initial visit ) &amp; Visit 3 ( 2 month initial visit ) : Questionnaire relating change may take place since recruitment . Brief physical examination study doctor . Overall participation : Over period 8 week . Sample Collection : At study visit , sample blood obtain ( approximately 6.5 tablespoon whole blood ) via one needle stick . A take-home stool sample collection kit provide . Stool sample obtain within 24 hour blood collection deliver ( mail ) study site . 2 kit provide initial visit , 1 kit provide follow visit month 1 .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Antiphospholipid Syndrome</mesh_term>
	<criteria>1870 year age One follow group : Group 1a : Persistently positive antiβ2GPI Coumadin ( n : 10 ) Group 1b : Persistently positive antiβ2GPI Coumadin ( n : 10 ) Group 2a : Negative aPL Coumadin ( n : 10 ) Group 2b : Negative aPL Coumadin ( n : 10 ) Persistently positive aβ2GPI define antiβ2GPI immunoglobulin G ( IgG ) /IgM/IgA ≥ 40 SGU/SMU two separate time point least 12 week apart . Negative aPL define negative Lupus anticoagulant test , aCL IgG/IgM/IgA , antiβ2GPI IgG/IgM/IgA within 12 month study entry . Any autoimmune disease include Rheumatoid Arthritis , Spondylarthropathy , Inflammatory Muscle Disease , Sarcoidosis Steroid use great 10 mg/d prednisone equivalent 30 day prior enrollment Any immunosuppressive drug use within 3 month prior screen ( mycophenolate mofetil , azathioprine , methotrexate , leflunomide , rituximab , cyclophosphamide , intravenous immunoglobulin , plasmapheresis ) . Ongoing chronic infection ( viral , bacterial fungal ) include know HIV , Hepatitis B/C Acute infection receive antibiotic within 30 day prior screen Acute thrombosis within 2 day prior screen Major gastrointestinal surgery le 5 year prior enrollment ( exception appendectomy ) Any Gastrointestinal bleeding history Inflammatory Bowel Disease diagnose biopsy Celiac Disease diagnose biopsy Bulimia anorexia nervosa Probiotics ( great estimate 10^9 cfu organism per day ) within 30 day prior enrollment ( exception ferment beverage , milk yogurt ) . Morbid obesity ( BMI ≥ 40 ) Diabetes Mellitus Type I II medical therapy Malignancy within one year prior screening ( exception nonmetastatic squamous basal cell skin carcinoma cervical carcinoma receive curative surgical treatment ) Known alcohol abuse Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>microbiome</keyword>
	<keyword>commensal</keyword>
	<keyword>autoantibody</keyword>
	<keyword>autoreactive T cell</keyword>
</DOC>